In 2006, Vianello and colleagues provided evidence that melanomas expressing elevated levels of CXCL12 can repel T cells, thereby abrogating Antigen (Ag)-specific T cell infiltration into the tumor and allowing it to escape immune control (24). This evidence concerns the gene CXCL12 and melanoma.